- Home
- HUT vs CNTA Comparison
HUT vs CNTA Comparison
Compare HUT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- CNTA
- Stock Information
- Founded
- HUT 2011
- CNTA 2020
- Country
- HUT United States
- CNTA United Kingdom
- Employees
- HUT N/A
- CNTA N/A
- Industry
- HUT Finance: Consumer Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HUT Finance
- CNTA Health Care
- Exchange
- HUT Nasdaq
- CNTA Nasdaq
- Market Cap
- HUT 2.2B
- CNTA 1.9B
- IPO Year
- HUT N/A
- CNTA 2021
- Fundamental
- Price
- HUT $23.32
- CNTA $18.05
- Analyst Decision
- HUT Strong Buy
- CNTA Strong Buy
- Analyst Count
- HUT 14
- CNTA 10
- Target Price
- HUT $27.36
- CNTA $30.56
- AVG Volume (30 Days)
- HUT 4.5M
- CNTA 1.1M
- Earning Date
- HUT 08-07-2025
- CNTA 08-12-2025
- Dividend Yield
- HUT N/A
- CNTA N/A
- EPS Growth
- HUT N/A
- CNTA N/A
- EPS
- HUT 1.48
- CNTA N/A
- Revenue
- HUT $138,543,000.00
- CNTA $15,000,000.00
- Revenue This Year
- HUT $74.79
- CNTA N/A
- Revenue Next Year
- HUT $116.78
- CNTA N/A
- P/E Ratio
- HUT $15.74
- CNTA N/A
- Revenue Growth
- HUT N/A
- CNTA 118.88
- 52 Week Low
- HUT $8.73
- CNTA $9.60
- 52 Week High
- HUT $31.95
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- HUT 62.22
- CNTA 68.40
- Support Level
- HUT $21.32
- CNTA $16.78
- Resistance Level
- HUT $21.71
- CNTA $17.37
- Average True Range (ATR)
- HUT 1.44
- CNTA 0.98
- MACD
- HUT 0.24
- CNTA 0.03
- Stochastic Oscillator
- HUT 88.89
- CNTA 98.04
About HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.